Literature DB >> 29423529

Structure and function of Zika virus NS5 protein: perspectives for drug design.

Boxiao Wang1, Stephanie Thurmond2, Rong Hai3, Jikui Song4.   

Abstract

Zika virus (ZIKV) belongs to the positive-sense single-stranded RNA-containing Flaviviridae family. Its recent outbreak and association with human diseases (e.g. neurological disorders) have raised global health concerns, and an urgency to develop a therapeutic strategy against ZIKV infection. However, there is no currently approved antiviral against ZIKV. Here we present a comprehensive overview on recent progress in structure-function investigation of ZIKV NS5 protein, the largest non-structural protein of ZIKV, which is responsible for replication of the viral genome, RNA capping and suppression of host interferon responses. Structural comparison of the N-terminal methyltransferase domain and C-terminal RNA-dependent RNA polymerase domain of ZIKV NS5 with their counterparts from related viruses provides mechanistic insights into ZIKV NS5-mediated RNA replication, and identifies residues critical for its enzymatic activities. Finally, a collection of recently identified small molecule inhibitors against ZIKV NS5 or its closely related flavivirus homologues are also discussed.

Entities:  

Keywords:  Antiviral inhibitors; Drug discovery; Flavivirus; Non-structural protein 5; Pathogen–host interaction; RNA capping; Viral replication

Mesh:

Substances:

Year:  2018        PMID: 29423529      PMCID: PMC5911220          DOI: 10.1007/s00018-018-2751-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  124 in total

1.  Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication.

Authors:  A E Matusan; M J Pryor; A D Davidson; P J Wright
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  The structural basis for RNA specificity and Ca2+ inhibition of an RNA-dependent RNA polymerase.

Authors:  Paula S Salgado; Eugene V Makeyev; Sarah J Butcher; Dennis H Bamford; David I Stuart; Jonathan M Grimes
Journal:  Structure       Date:  2004-02       Impact factor: 5.006

3.  Discovery of Potent Non-Nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from a Fragment Hit Using Structure-Based Drug Design.

Authors:  Fumiaki Yokokawa; Shahul Nilar; Christian G Noble; Siew Pheng Lim; Ranga Rao; Stefani Tania; Gang Wang; Gladys Lee; Jürg Hunziker; Ratna Karuna; Ujjini Manjunatha; Pei-Yong Shi; Paul W Smith
Journal:  J Med Chem       Date:  2016-04-08       Impact factor: 7.446

Review 4.  Molecular mechanisms involved in the early steps of flavivirus cell entry.

Authors:  Bärbel Kaufmann; Michael G Rossmann
Journal:  Microbes Infect       Date:  2010-12-10       Impact factor: 2.700

5.  Expression, purification, and characterization of the RNA 5'-triphosphatase activity of dengue virus type 2 nonstructural protein 3.

Authors:  Greg Bartelma; R Padmanabhan
Journal:  Virology       Date:  2002-07-20       Impact factor: 3.616

6.  Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression.

Authors:  Kirk J Lubick; Shelly J Robertson; Kristin L McNally; Brett A Freedman; Angela L Rasmussen; R Travis Taylor; Avram D Walts; Seitaro Tsuruda; Mizuki Sakai; Mariko Ishizuka; Elena F Boer; Erin C Foster; Abhilash I Chiramel; Conrad B Addison; Richard Green; Daniel L Kastner; Michael G Katze; Steven M Holland; Antonella Forlino; Alexandra F Freeman; Manfred Boehm; Kentaro Yoshii; Sonja M Best
Journal:  Cell Host Microbe       Date:  2015-07-08       Impact factor: 21.023

7.  Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling.

Authors:  Alesha Grant; Sanket S Ponia; Shashank Tripathi; Vinod Balasubramaniam; Lisa Miorin; Marion Sourisseau; Megan C Schwarz; Mari Paz Sánchez-Seco; Matthew J Evans; Sonja M Best; Adolfo García-Sastre
Journal:  Cell Host Microbe       Date:  2016-05-19       Impact factor: 21.023

8.  Development of a S-adenosylmethionine analog that intrudes the RNA-cap binding site of Zika methyltransferase.

Authors:  Rinku Jain; Kyle V Butler; Javier Coloma; Jian Jin; Aneel K Aggarwal
Journal:  Sci Rep       Date:  2017-05-09       Impact factor: 4.379

9.  AXL is not essential for Zika virus infection in the mouse brain.

Authors:  Feng Li; Pei-Rong Wang; Lin-Bing Qu; Chang-Hua Yi; Fu-Chun Zhang; Xiao-Ping Tang; Li-Guo Zhang; Ling Chen
Journal:  Emerg Microbes Infect       Date:  2017-03-29       Impact factor: 7.163

10.  Nucleic acid polymerases use a general acid for nucleotidyl transfer.

Authors:  Christian Castro; Eric D Smidansky; Jamie J Arnold; Kenneth R Maksimchuk; Ibrahim Moustafa; Akira Uchida; Matthias Götte; William Konigsberg; Craig E Cameron
Journal:  Nat Struct Mol Biol       Date:  2009-01-18       Impact factor: 15.369

View more
  18 in total

1.  Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication by inhibiting the activation of protein kinase PKR.

Authors:  Shili Zhou; Chao Yang; Fanfan Zhao; Yanxia Huang; Yuxia Lin; Changbai Huang; Xiaocao Ma; Jingjie Du; Yi Wang; Gang Long; Junfang He; Chao Liu; Ping Zhang
Journal:  J Biol Chem       Date:  2019-10-21       Impact factor: 5.157

2.  Rottlerin plays an antiviral role at early and late steps of Zika virus infection.

Authors:  Shili Zhou; Quanshi Lin; Changbai Huang; Xiaotong Luo; Xu Tian; Chao Liu; Ping Zhang
Journal:  Virol Sin       Date:  2022-08-05       Impact factor: 6.947

Review 3.  Dual-Role Ubiquitination Regulation Shuttling the Entire Life Cycle of the Flaviviridae.

Authors:  Dongjie Cai; Lingli Liu; Bin Tian; Xingxin Fu; Qiyuan Yang; Jie Chen; Yilin Zhang; Jing Fang; Liuhong Shen; Ya Wang; Liping Gou; Zhicai Zuo
Journal:  Front Microbiol       Date:  2022-05-06       Impact factor: 6.064

4.  Suppression of Zika Virus Infection in the Brain by the Antiretroviral Drug Rilpivirine.

Authors:  Ilker Kudret Sariyer; Jennifer Gordon; Tricia H Burdo; Hassen S Wollebo; Eleonora Gianti; Martina Donadoni; Anna Bellizzi; Stephanie Cicalese; Regina Loomis; Jake A Robinson; Vincenzo Carnevale; Joseph Steiner; Mehmet H Ozdener; Andrew D Miller; Shohreh Amini; Michael L Klein; Kamel Khalili
Journal:  Mol Ther       Date:  2019-10-11       Impact factor: 11.454

5.  Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP.

Authors:  Mahamaya Biswal; Stephen Diggs; Duo Xu; Nelli Khudaverdyan; Jiuwei Lu; Jian Fang; Gregor Blaha; Rong Hai; Jikui Song
Journal:  Nucleic Acids Res       Date:  2021-06-04       Impact factor: 16.971

6.  Chimeric Zika viruses containing structural protein genes of insect-specific flaviviruses cannot replicate in vertebrate cells due to entry and post-translational restrictions.

Authors:  Chandra S Tangudu; Jermilia Charles; Daniel Nunez-Avellaneda; Alissa M Hargett; Aaron C Brault; Bradley J Blitvich
Journal:  Virology       Date:  2021-03-26       Impact factor: 3.513

7.  Development of a fluorescence-based method for the rapid determination of Zika virus polymerase activity and the screening of antiviral drugs.

Authors:  Yanira Sáez-Álvarez; Armando Arias; Carmen Del Águila; Rubén Agudo
Journal:  Sci Rep       Date:  2019-04-01       Impact factor: 4.379

Review 8.  Evolution of Two Major Zika Virus Lineages: Implications for Pathology, Immune Response, and Vaccine Development.

Authors:  Jacob T Beaver; Nadia Lelutiu; Rumi Habib; Ioanna Skountzou
Journal:  Front Immunol       Date:  2018-07-18       Impact factor: 7.561

9.  Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus.

Authors:  Jie Yuan; Jianchen Yu; Yun Huang; Zhenjian He; Jia Luo; Yun Wu; Yingchun Zheng; Jueheng Wu; Xun Zhu; Haihe Wang; Mengfeng Li
Journal:  BMC Med       Date:  2020-07-31       Impact factor: 8.775

10.  Functional and evolutionary analysis of viral proteins containing a Rossmann-like fold.

Authors:  Kirill E Medvedev; Lisa N Kinch; Nick V Grishin
Journal:  Protein Sci       Date:  2018-06-13       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.